These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3867111

  • 1. Normal antithrombin-III activity and concentration in experimental disseminated intravascular coagulation.
    Müller-Berghaus G, Niepoth M, Rabens-Alles B, Rump E, Murano G.
    Scand J Clin Lab Invest Suppl; 1985; 178():107-13. PubMed ID: 3867111
    [No Abstract] [Full Text] [Related]

  • 2. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J, Brüggener E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [Abstract] [Full Text] [Related]

  • 3. [Antithrombin III and heparin].
    Zhu KC.
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):177-9. PubMed ID: 3058418
    [No Abstract] [Full Text] [Related]

  • 4. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
    Marbet GA, Griffith MJ.
    Thromb Haemost; 1986 Feb 28; 55(1):78-85. PubMed ID: 3518133
    [Abstract] [Full Text] [Related]

  • 5. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM, Eurenius K.
    Am J Clin Pathol; 1976 Sep 28; 66(3):488-94. PubMed ID: 60879
    [Abstract] [Full Text] [Related]

  • 6. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T, Jespersen J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Sep 28; 111(4):407-15. PubMed ID: 6083904
    [Abstract] [Full Text] [Related]

  • 7. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
    Soulier JP, Gozin D, Lerable J.
    Thromb Res; 1984 May 01; 34(3):255-62. PubMed ID: 6729779
    [Abstract] [Full Text] [Related]

  • 8. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J, Brüggener E, Markwardt F.
    Haemostasis; 1987 May 01; 17(6):321-8. PubMed ID: 3428717
    [Abstract] [Full Text] [Related]

  • 9. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL, Bick MD, Fekete LF.
    Am J Clin Pathol; 1980 Apr 01; 73(4):577-83. PubMed ID: 7369182
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H.
    Semin Thromb Hemost; 1989 Jul 01; 15(3):347-52. PubMed ID: 2688106
    [No Abstract] [Full Text] [Related]

  • 11. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
    Dickneite G, Czech J, Keuper H.
    Circ Shock; 1994 Apr 01; 42(4):183-9. PubMed ID: 8055664
    [Abstract] [Full Text] [Related]

  • 12. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434
    [Abstract] [Full Text] [Related]

  • 13. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
    Kazama Y, Takahashi K, Oguma Y, Sakuragawa N.
    Rinsho Ketsueki; 1988 Mar 31; 29(3):344-8. PubMed ID: 3398266
    [No Abstract] [Full Text] [Related]

  • 14. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S.
    Am J Hematol; 1996 Sep 31; 53(1):18-21. PubMed ID: 8813091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Biokhimiia; 1981 Nov 31; 46(11):2024-9. PubMed ID: 7317530
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the usefulness of antithrombin-III in the management of disseminated intravascular coagulation in obstetrically Ill patients.
    Kobayashi A, Matsuda Y, Mitani M, Makino Y, Ohta H.
    Clin Appl Thromb Hemost; 2010 Dec 31; 16(6):688-93. PubMed ID: 19833617
    [Abstract] [Full Text] [Related]

  • 18. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G, Reiter B, Hellstern P, Wenzel E, Köhler M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Dec 31; 111(4):426-38. PubMed ID: 6083907
    [Abstract] [Full Text] [Related]

  • 19. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA, Griffith MJ, Roberts HR.
    Scand J Clin Lab Invest Suppl; 1985 Dec 31; 178():95-8. PubMed ID: 3867125
    [Abstract] [Full Text] [Related]

  • 20. Effect of a synthetic thrombin inhibitor MCI-9038 on experimental models of disseminated intravascular coagulation in rabbits.
    Hara H, Tamao Y, Kikumoto R, Okamoto S.
    Thromb Haemost; 1987 Apr 07; 57(2):165-70. PubMed ID: 3603410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.